MeganClowseMD
Rheumatology • Durham, NCAssociate Professor, Medicine, Duke University School of Medicine
Dr. Clowse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Duke Medical Ctr
Durham, NC 27710Phone+1 919-620-4467
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 2003 - 2005
MedStar Health (Baltimore)Residency, Internal Medicine, 1999 - 2002
Vanderbilt University School of MedicineClass of 1999
Certifications & Licensure
NC State Medical License 2005 - 2025
MD State Medical License 2003 - 2006- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow American College of Rheumatology
Clinical Trials
- Duke Lupus Registry Start of enrollment: 2007 Jul 01
- Duke Autoimmunity in Pregnancy Registry Start of enrollment: 2007 Aug 01
- Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) Start of enrollment: 2013 Nov 20
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsHydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data.Megan E B Clowse, Amanda M Eudy, Stephen Balevic, Gillian Sanders-Schmidler, Andrzej Kosinski
Lupus Science & Medicine. 2022-03-01 - 15 citationsHydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes.Stephen J Balevic, Daniel Weiner, Megan E B Clowse, Amanda M Eudy, Anil R Maharaj
Lupus Science & Medicine. 2022-01-01 - 27 citationsHydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.Stephen J. Balevic, Michael Cohen-Wolkowiez, Amanda M Eudy, Thomas P. Green, Laura E. Schanberg
The Journal of Rheumatology. 2019-01-01
Journal Articles
- Patient‐Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid ArthritisNathaniel Harris, Megan Clowse, Arthritis Care & Research
Other
- General toxicity of cyclophosphamide and chlorambucil in inflammatory diseasesClowse MB, Stone JH
http://www.uptodate.com/contents/general-toxicity-of-cyclophosphamide-and-chlorambucil-in-inflammato
UpToDate, Wolters Kluwer Health - 2013-03-07
Authored Content
- Dapirolizumab Pegol Demonstrated Significant Improvement in Systemic Lupus Erythematosus Disease Activity: Efficacy and Safety Results of a Phase 3 TrialOctober 2024
- Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic PainApril 2016
- Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic PainApril 2016
- Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic PainReporting of Sex Effects by Systematic Reviews on InterventionsApril 2016
- Join now to see all
Press Mentions
Belimumab for Pregnant Women with Lupus: B-cell Concerns RemainJanuary 17th, 2023- Belimumab for Pregnant Women with Lupus: B-cell Concerns RemainJanuary 17th, 2023
- Challenges in Reproductive Health in Rheumatic DiseaseJuly 11th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
